Any student or school personnel who exhibit symptoms of COVID-19, as defined by the CDC, should stay home until they test negative for COVID-19, or for a minimum of 10 days, until they are fever free for 24 hours and until 48 hours after diarrhea or vomiting have ceased....
The governor was asked about the CDC's recommendation to start expanding the distribution of the vaccine. He said any changes to the Massachusetts timeline will come after getting advice from the state's COVID-19 Vaccine Advisory Group. Right now, Massachusetts is still in phase one...
(AP) — The federal government has told states to prepare for a coronavirus vaccine to be ready to distribute by Nov. 1. The timeline raised concern among public health experts about an “October surprise” — a vaccine approval driven by political considerations ahead of a presidential electio...
A second U.S. study covering a timeline of patients with a COVID-19 diagnosis and surgery up to May 31, 2021 reviewed 5479 surgical patients following COVID-19 infection.Immunization status was not given but the study period ranged from a time of zero vaccination until a period when about ...
ADDIS ABABA, March 25 (Xinhua) -- The death toll from the ongoing COVID-19 pandemic in the African continent has reached 64 as confirmed positives cases surpassed 2,412 as of Wednesday, the Africa Center for Disease Control and Prevention (Africa CDC) revealed on Wednesday. ...
Exact Timeline and Additional Details Even with the remaining hurdles, the industry response to the new CDC guidance is mostly positive. As to when cruising from the U.S. might officially start to move forward, the CDC’s statement pointed to summer: “CDC remains committed to the resumption ...
Relapsing COVID-19 patients can end their second isolation period after five days if their symptoms are improving and they haven't had a fever in 24 hours—but they should still continue to wear a mask around others for five additional days, to complete the CDC-recommended 10 days of isolat...
Inactive Organization Merck & Co., Inc. Drug Highest PhasePhase 3 First Approval Date- Regulation- Login to view timeline Structure Molecular FormulaC25H23ClN4O4 InChIKeyJSFCZQSJQXFJDS-QAPCUYQASA-N CAS Registry2095393-15-8 Related 21 Clinical Trials associated with Nemtabrutinib NCT06572618 /...